People

Robert Hughes

Robert Hughes, also published as Rob Hughes, is an Atlas adviser and EVP of drug discovery and preclinical development at Rectify Pharmaceuticals. His biography describes earlier molecular-discovery leadership at Disarm and research positions at Boehringer Ingelheim and Pfizer, including neurodegeneration. He earned a Scripps chemistry PhD and an Arizona chemistry/mathematics degree. He is distinct from the STRM.BIO finance executive with the same name.